These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8840491)

  • 21. Urodynamic effects of transrectal intraprostatic Ona botulinum toxin A injections for symptomatic benign prostatic hyperplasia.
    de Kort LM; Kok ET; Jonges TN; Rosier PF; Bosch JL
    Urology; 2012 Oct; 80(4):889-93. PubMed ID: 22854138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The relationship between intravesical prostatic protrusion and pressure flow study findings in patients with benign prostate obstruction/lower urinary tract symptoms].
    Park SC; Lee JW; Rim JS
    Actas Urol Esp; 2012 Mar; 36(3):165-70. PubMed ID: 22018947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Intravesical prostatic protrusion in diagnosing infravesical obstruction in men with benign prostatic hyperplasia].
    Krivoborodov GG; Efremov NS; Bolotov AD
    Urologiia; 2017 Jun; (2):105-109. PubMed ID: 28631916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostatic elasticity: a new non-invasive parameter to assess bladder outlet obstruction caused by benign prostatic hyperplasia (a canine experiment).
    Fu S; Zhang M; Wang Y; Li Q; Tang J
    Urology; 2013 Nov; 82(5):1114-9. PubMed ID: 24242892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation between morphometric differences and norepinephrine content in benign prostatic hyperplasia.
    Ishigooka M; Hashimoto T; Hayami S; Suzuki Y; Sasagawa I; Nakada T
    Prostate; 1996 Jun; 28(6):385-91. PubMed ID: 8650076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of silodosin for relieving benign prostatic obstruction: prospective pressure flow study.
    Matsukawa Y; Gotoh M; Komatsu T; Funahashi Y; Sassa N; Hattori R
    J Urol; 2009 Dec; 182(6):2831-5. PubMed ID: 19837428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Doppler resistive index in benign prostatic hyperplasia: correlation with ultrasonic appearance of the prostate and infravesical obstruction.
    Kojima M; Ochiai A; Naya Y; Okihara K; Ukimura O; Miki T
    Eur Urol; 2000 Apr; 37(4):436-42. PubMed ID: 10765074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of dutasteride on storage and voiding symptoms in male patients with lower urinary tract symptoms as a result of benign prostatic obstruction: the 1-year outcomes from a prospective urodynamic study.
    Matsukawa Y; Gotoh M; Kato M; Funahashi Y; Narita M; Mitsui K
    Int J Urol; 2014 Aug; 21(8):826-30. PubMed ID: 24661225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does digital rectal examination affect uroflowmetry measurements?
    Aybek Z; Sinik Z; Oguzulgen I; Turan T; Güler G; Tuncay L
    Neurourol Urodyn; 2003; 22(2):138-41. PubMed ID: 12579631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Interrelation of hyperactivity of bladder and infravesical obstruction in patients with benign prostate hyperplasia].
    Bablumyan A
    Georgian Med News; 2010 Dec; (189):7-11. PubMed ID: 21252402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical significance of intravesical prostatic protrusion in patients with benign prostatic enlargement.
    Keqin Z; Zhishun X; Jing Z; Haixin W; Dongqing Z; Benkang S
    Urology; 2007 Dec; 70(6):1096-9. PubMed ID: 18158025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of persistent storage symptoms after transurethral resection of the prostate in patients with benign prostatic enlargement.
    Choi H; Kim JH; Shim JS; Park JY; Kang SH; Moon du G; Cheon J; Lee JG; Kim JJ; Bae JH
    Urol Int; 2014; 93(4):425-30. PubMed ID: 25300422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Age and bladder outlet obstruction are independently associated with detrusor overactivity in patients with benign prostatic hyperplasia.
    Oelke M; Baard J; Wijkstra H; de la Rosette JJ; Jonas U; Höfner K
    Eur Urol; 2008 Aug; 54(2):419-26. PubMed ID: 18325657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relationship of the International Prostate Symptom Score and objective parameters for diagnosing bladder outlet obstruction. Part I: when statistics fail.
    Wadie BS; Ibrahim EH; de la Rosette JJ; Gomha MA; Ghoneim MA
    J Urol; 2001 Jan; 165(1):32-4. PubMed ID: 11125357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Editorial comment on: diagnostic accuracy of noninvasive tests to evaluate bladder outlet obstruction in men: detrusor wall thickness, uroflowmetry, postvoid residual urine, and prostate volume.
    Gratzke C; Reich O
    Eur Urol; 2007 Sep; 52(3):835. PubMed ID: 17207917
    [No Abstract]   [Full Text] [Related]  

  • 36. Intravesical prostatic protrusion can be a predicting factor for the treatment outcome in patients with lower urinary tract symptoms due to benign prostatic obstruction treated with tamsulosin.
    Cumpanas AA; Botoca M; Minciu R; Bucuras V
    Urology; 2013 Apr; 81(4):859-63. PubMed ID: 23375910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Correlation of serum prostate specific antigen, the volume and the intravesical prostatic protrusion for diagnosing bladder outlet obstruction in patients with benign prostate hyperplasia].
    Bantis A; Zissimopoulos A; Kalaytzis C; Giannakopoulos S; Sountoulides P; Agelonidou E; Voudalikakis C; Touloupidis S
    Hell J Nucl Med; 2007; 10(2):138-43. PubMed ID: 17684595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of silodosin for relieving benign prostatic obstruction: prospective pressure flow study.
    Matsukawa Y; Gotoh M; Komatsu T; Funahashi Y; Sassa N; Hattori R
    J Urol; 2013 Jan; 189(1 Suppl):S117-21. PubMed ID: 23234615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Analysis of the diagnostic criteria of bladder outlet obstruction in benign prostatic hyperplasia].
    Shuang W; Wang D; Zhang X; Liu C; Cao X; Wang J; Gao J; Ren Z; Lü Y
    Zhonghua Nan Ke Xue; 2004 Oct; 10(10):743-6. PubMed ID: 15562786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in the bladder wall muscle associated with benign prostatic enlargement. A clinical and morphometric study.
    Jakse G; Hoffstädter F
    Urol Res; 1977; 5(3):149-52. PubMed ID: 72445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.